Searchable abstracts of presentations at key conferences in endocrinology

ea0029p21 | Adrenal cortex | ICEECE2012

Predicting factors of the post-surgical decline in renal function in patients with primary aldosteronism

Nakao K. , Nanba K. , Tamanaha T. , Tsuki M. , Tagami T. , Usui T. , Shimatsu A. , Naruse M.

Primary aldosteronism (PA) is the most common cause of secondary hypertension. Although decline in renal function especially that experienced after adrenalectomy (ADX) has been demonstrated, details of the mechanism remain to be elucidated. Aim of the study was to investigate the factors predicting renal outcome after ADX in PA. Twenty patients with PA and four patients with non-functioning adrenal tumor (NFT) as control were studied. eGFR, serum potassium, plasma aldosterone ...

ea0026p280 | Pituitary | ECE2011

Immunoglobulin G4-related infundibulo-hypophysitis: report of 4 cases and review of the literature

Shimatsu A , Nanba K , Oki Y , Tagami T , Usui T , Naruse M

Inflammatory lesions of the pituitary gland are rarely encountered. Recently, the concept of IgG4-related systemic disease was proposed and several cases associated with infundibulo-hypophysitis were reported. We report 4 additional cases and review the cases in the literature. Case 1: 75-year-old female had diabetes insipidus due to infundibulo-neurohypophysitis for 25 years and chronic thyroiditis. She developed obstructive jaundice and surgery showed autoimmune pancreatitis...

ea0029p2 | Adrenal cortex | ICEECE2012

Pathophysiological significance of CYP11B2 immunohistochemical staining in primary aldosteronism

Nanba K. , Tsuiki M. , Sawai K. , Mukai K. , Nakao K. , Tamanaha T. , Usui T. , Tagami T. , Okuno H. , Yamamoto T. , Shimatsu A. , Naruse M.

Background: Although primary aldosteronism (PA) is the common cause of hypertension subjected to surgery, methods of pathological confirmation of aldosterone overproduction have not been established. Aim of the study was to investigate immunohistochemically the expression of CYP11B2 in the adrenal tissue of PA.Methods: Twenty five patients with PA including 20 patients with aldosterone-producing adenoma (APA) and 5 patients without APA (non-APA) were stu...

ea0029p217 | Calcium & Vitamin D metabolism | ICEECE2012

Usefulness of MS-MLPA for detection of genetic and epigenetic states of GNAS complex in Pseudohypoparathyroidism type1b

Yuno A. , Usui T. , Yambe Y. , Higashi K. , Yokota I. , Mashio Y. , Shinoda J. , Shimatsu A.

Objective: Pseudohypoparathyroidism type 1b (PHP-1b) is rare disorders resulting from genetic and epigenetic aberrations in the GNAS locus. PHP-1b usually defined by isolated renal resistance to PTH, is due to a maternal loss of GNAS exonA/B methylation, leading to decreased Gs’α expression in specific tissues. To clarify the usefulness of methylation specific multiplex ligation-dependent probe amplification (MS-MLPA), we evaluate the genetic and epigenetic changes o...

ea0029p491 | Developmental endocrinology | ICEECE2012

DHEA attenuated mature adipocyte proliferation

Mori I. , Kajita K. , Fujioka K. , Hanamoto T. , Ikeda T. , Okada H. , Usui T. , Takahashi N. , Taguchi K. , Kitada Y. , Uno Y. , Morita H. , Ishizuka T.

Back ground: Numerous researches indicate that DHEA administration decreases fat mass in human and rodent. We evaluated the effects of DHEA treatment on adiposity. Male Otsuka Long evans fatty (OLETF) rats, hereditary obese type 2 diabetic animals derived from long evans tokushima (LETO) rats. These rats were fed with or without (control) 0.4% DHEA containing food for 52 weeks. Telomere length as a marker of whole cell division in adipose tissue were assessed. Genomic DNA isol...

ea0029p1837 | Thyroid cancer | ICEECE2012

A novel tandem germline RET mutations on the same allele in a patient with MEN 2B

Nakao K. , Usui T. , Ikeda M. , Mori Y. , Kawashima S. , Nanba K. , Tamanaha T. , Tagami T. , Naruse M. , Yamamoto T. , Shimatsu A.

Multiple endocrine neoplasia type2 (MEN 2) (OMIM 171400) is an autosomal dominant inherited cancer syndrome caused by activating mutations in the RET proto-oncogene. MEN 2 is classified into three subtypes: MEN 2A, MEN 2B and familial medullary thyroid carcinoma(FMTC). MEN 2B accounts for 5–10% of MEN2 cases. More than 95% of MEN 2B patients carry M918T mutation of RET, and 2–3% harbor A883F mutation. There has been three reports of cases with MEN 2B phenotype caused...